ClinicalTrials.gg
RecruitingNCT06339814Updated Apr 1, 2024

Eye Movement Desensitization and Reprocessing Group Treatment for Caregivers of Pediatric Brain Tumor Patients

An interventional study of Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol and Treatment As Usual in Caregiver Burden, sponsored by IRCCS Eugenio Medea. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-04-01.

Sponsored by IRCCS Eugenio Medea · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Registered 1 year after the study started (first participant enrolled Mar 2023, registered Mar 2024).
  • Started Mar 2023; still recruiting 3 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
48
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Caregiver Burden with a site in Italy — 3 open to participants now, 4 under way, none of them phase 3. Caregiver Burden · Italy.

Started
2023
with 1 other
No phase
9 of 10
3 open now
Registered
7th of 10
by date
Lead sponsor
1 of 10
IRCCS Eugenio Medea

Among the 10 studies in Caregiver Burden with a site in Italy, this one is one of 2 that started in 2023, is one of 9 with no phase, and was the 7th registered.

Caregiver Burden

503 studies on the registry are indexed under Caregiver Burden; 166 are open to participants now.

Browse Caregiver Burden studies →

Open to participants now

3 of the 10 studies in Caregiver Burden with a site in Italy are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 90 Caregiver Burden studies recruiting now, 69 (77%) set no upper age limit and 7 (8%) stop at 75 or younger; 8 take children under 18; 39 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Caregiver Burden with a site in Italy, or all of them as a file.
02

Study summary

Caregivers of pediatric brain tumor survivors may develop high levels of psychological distress, mostly depression and anxiety, with effects comparable to those of a traumatic event. Several studies suggest that Eye Movement Desensitization and Reprocessing could be a promising treatment in similar clinical populations (i.e. adults with brain tumor), but it has never been used for caregivers of pediatric brain tumor. The aims of the present study will be to test the feasibility of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for caregivers of pediatric brain tumor survivors in a clinical setting and to evaluate its effectiveness in decreasing the psychological distress in this population. The study will be monocentric, and with two parallel branches: the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol group, who will receive a 4-session treatment, versus the Treatment as Usual condition, who will receive standard support. Emotional distress will be measured before the treatment, immediately after the end of it, and two months later (follow-up), by means of several clinical scales. Twenty-four subjects will be recruited for each group (caregivers and controls). Statistical analysis will be performed to test the effect of the intervention. If a positive outcome occurs, it could offer preliminary results about the validity of the Eye Movement Desensitization and Reprocessing in treating this population's difficulties.

Read the detailed description

Pediatric cancer is a stressful life event, with a huge impact both on the diagnosed children and on their parents, comparable to that of a traumatic event. Caregivers of pediatric brain tumor survivors show several psychological difficulties, such as symptoms of anxiety, depression, and post-traumatic stress disorder. The presence of psychological distress throughout the oncological path of the child causes a long-term high burden impact, leading to an increased need for psychological support from the caregivers.

The Eye Movement Desensitization and Reprocessing has never been used for caregivers of pediatric brain tumor: neither individual nor Integrative Group Treatment Protocol. Hence, the aims of the present study are: (1) to test the feasibility of the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol for caregivers of patients with pediatric brain tumor in a clinical setting; (2) to evaluate whether Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol is effective in decreasing psychological distress in caregivers.

Several studies suggest that Eye Movement Desensitization and Reprocessing could be a promising treatment for psychological distress, given the existing literature on caregivers of adult patients with brain tumor or dementia.

Design: The study will be monocentric, with two parallel branches, thus conforming to a Randomized Group Treatment Trial: Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol (those who will receive Eye Movement Desensitization and Reprocessing treatment plus the standard support) versus Treatment As Usual condition (those who will receive only standard support). The assessment will be performed at the moment of recruitment (T0), after the intervention for the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol group and after 1 month for the Treatment As Usual condition (T1), and for both 2 months after T1 (T2).

Participants: Pediatric brain tumor caregivers and controls (24 subjects in each, 48 subjects in total) will be recruited at La Nostra Famiglia, IRCCS E. Medea, Bosisio Parini (LC), Italy. Inclusion criteria: being the primary caregivers of a patient with a diagnosis of brain tumor, with evidence of one or more traumatic events causing trauma related symptoms (Impact of Event Scale-Revised > 0, and Subjective Units of Distress > 5); being fluent in Italian and with at least three years of education. Exclusion criteria: Evidence of severe psychiatric disorders. Block randomization will be performed to ensure a balance in sample size across groups over time.

Caregivers' assessment will include: a data form to collect clinical and socio-demographic features (age, gender, educational level, occupation, type of pediatric brain tumor, treatments ...), a feasibility questionnaire (only for the feasibility study), the Impact of Event Scale-Revised, the Subjective Units of Distress, the State-Trait Anxiety Inventory, the Beck Depression In-ventory, the Parenting Stress Index, the Caregiver Burden Inventory, and the Family Assessment Device 3.

Intervention: An Eye Movement Desensitization and Reprocessing psychotherapist will hold the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol sessions, dedicated to psychoeducation, imagery exercises, stabilization techniques and the reprocessing of traumatic events. The Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol will be composed of 4 sessions of 120 minutes each. The number of the sessions has been chosen referring to the literature and based on the length of the hospitalization in the Institute. In the case of an emergency (e.g. increased number of Covid-19 cases), groups can also be held online. Supervision by an Eye Movement Desensitization and Reprocessing practitioner will be requested.

Analyses: (i) Spearman's correlations to test the relationship between clinical and socio-demographical variables; (ii) A series of generalized linear mixed models with clinical variables (outcomes of the psychological tests) as dependent variables, random intercept (grouped by subject) and with time (T0 versus T1 versus T2) and branch (Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol versus Treatment As usual) as fixed effect predictors to test the intervention.

If a decrease in the psychological symptoms occurs, it could offer preliminary results about the validity of the Eye Movement Desensitization and Reprocessing in alleviating the difficulties caregivers have in caring for pediatric BT survivor, easing the burden of an oncological disease with an unpredictable progression. Possible limitations of the study could include dropouts, the need for a wider sample for more rigorous results or a longer-term assessment (i.e. 6 months after the end of Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol ) to evaluate the stabilization of the positive effects.

03

Conditions studied

  • Caregiver Burden

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • being the primary caregivers of a patient with a diagnosis of brain tumor,
  • evidence of one or more traumatic events causing trauma related symptoms (Impact of Event Scale-Revised > 0, and Subjective Units of Distress > 5);
  • being fluent in Italian
  • with at least three years of education.

Exclusion criteria

Exclusion Criteria:

  • Evidence of severe psychiatric disorders.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
48 participants (estimated)

Study arms

  • Experimental
    Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol

    Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol will receive Eye Movement Desensitization and Reprocessing treatment plus the standard support

    Other: Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol · Other: Treatment As Usual

  • Active comparator
    Treatment As Usual group

    Treatment As Usual group will receive only standard support

    Other: Treatment As Usual

Interventions

  • OtherEye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol

    An Eye Movement Desensitization and Reprocessing psychotherapist will hold the Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol sessions, dedicated to psychoeducation, imagery exercises, stabilization techniques and the reprocessing of traumatic events. The Eye Movement Desensitization and Reprocessing Integrative Group Treatment Protocol will be composed of 4 sessions of 120 minutes each.

  • OtherTreatment As Usual

    Treatment As Usual condition will receive only standard support.

06

What researchers measure

Primary outcomes

  1. Impact of Event Scale-Revised-Total score

    The Impact of Event Scale - Revised was designed as a measure of post-traumatic stress disorder symptoms, and is a short, easily administered self-report questionnaire. It can be used for repeated measurements over time to monitor progress and is best used for recent and specific traumatic events. Minimum-maximum value:0-88. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  2. Impact of Event Scale-Revised-Intrusion score

    The Impact of Event Scale - Revised was designed as a measure of post-traumatic stress disorder symptoms, and is a short, easily administered self-report questionnaire. It can be used for repeated measurements over time to monitor progress and is best used for recent and specific traumatic events. Minimum-maximum value:0-32;maximum mean score: 4. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  3. Impact of Event Scale-Revised-Avoidance score

    The Impact of Event Scale - Revised was designed as a measure of post-traumatic stress disorder symptoms, and is a short, easily administered self-report questionnaire. It can be used for repeated measurements over time to monitor progress and is best used for recent and specific traumatic events. Minimum-maximum value:0-32;maximum mean score: 4. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  4. Impact of Event Scale-Revised-Hyperarousal score

    The Impact of Event Scale - Revised was designed as a measure of post-traumatic stress disorder symptoms, and is a short, easily administered self-report questionnaire. It can be used for repeated measurements over time to monitor progress and is best used for recent and specific traumatic events. Minimum-maximum value:0-24;maximum mean score: 4. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  5. Subjective Units of Distress-Total Score

    The Subjective Units of Distress Scale is a tool for measuring the intensity of feelings and other internal experiences, such as anxiety, anger, agitation, stress or other painful feelings. The score ranges between 0 (no disturbance) and 10 (maximum perceived disturbance). Minimum-maximum value:0-10. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  6. State-Trait Anxiety Inventory-State anxiety score

    The State-Trait Anxiety Inventory is a 40-item self-report scale that assesses separate dimensions of "state" and "trait" anxiety. Examples of what the the tool measures include feelings of apprehension, tension, nervousness, and worry. Minimum-maximum value: 20-80. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  7. State-Trait Anxiety Inventory-Trait anxiety score

    The State-Trait Anxiety Inventory is a 40-item self-report scale that assesses separate dimensions of "state" and "trait" anxiety. Examples of what the the tool measures include feelings of apprehension, tension, nervousness, and worry. Minimum-maximum value: 20-80. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  8. Beck Depression Inventory-Total score

    The Beck Depression Inventory is a 21-item, multiple-choice inventory. Respondents are asked to rate each item based on four response choices according to the severity of the symptoms, ranging from the absence of a symptom to an intense level, during the past week. Minimum-maximum value: 0-63. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  9. Parenting Stress Index-Total score

    The Parenting Stress Index is used to measure the relative stress in the parent-child relationship. It can be used for parents of children up to 12 years. Minimum-maximum value: 36-180. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  10. Parenting Stress Index-Parental stress score

    The Parenting Stress Index is used to measure the relative stress in the parent-child relationship. It can be used for parents of children up to 12 years. Minimum-maximum value: 12-60. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  11. Parenting Stress Index-Dysfunctional interaction score

    The Parenting Stress Index is used to measure the relative stress in the parent-child relationship. It can be used for parents of children up to 12 years. Minimum-maximum value: 12-60. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  12. Parenting Stress Index-Hard child score

    The Parenting Stress Index is used to measure the relative stress in the parent-child relationship. It can be used for parents of children up to 12 years. Minimum-maximum value: 12-60. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  13. Stress Index for Parents of Adolescents-Total stress score

    The Stress Index for Parents of Adolescents is a screening and diagnostic instrument that identifies areas of stress in parent-adolescent interactions, allowing examination of the relationship of parenting stress to adolescent characteristics, parent characteristics, the quality of the adolescent-parent interactions, and stressful life circumstances. It can be used for parents of children between 11 and 19 years. Minimum-maximum value: 112-560. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  14. Stress Index for Parents of Adolescents-Life restrictions score

    The Stress Index for Parents of Adolescents is a screening and diagnostic instrument that identifies areas of stress in parent-adolescent interactions, allowing examination of the relationship of parenting stress to adolescent characteristics, parent characteristics, the quality of the adolescent-parent interactions, and stressful life circumstances. It can be used for parents of children between 11 and 19 years. Minimum-maximum value: 10-50. Higher scores mean worse outcome

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  15. Stress Index for Parents of Adolescents-Relationship with spouse/partner score

    The Stress Index for Parents of Adolescents is a screening and diagnostic instrument that identifies areas of stress in parent-adolescent interactions, allowing examination of the relationship of parenting stress to adolescent characteristics, parent characteristics, the quality of the adolescent-parent interactions, and stressful life circumstances. It can be used for parents of children between 11 and 19 years. Minimum-maximum value: 9-45. Higher scores mean worse outcome

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  16. Stress Index for Parents of Adolescents-Social alienation score

    The Stress Index for Parents of Adolescents is a screening and diagnostic instrument that identifies areas of stress in parent-adolescent interactions, allowing examination of the relationship of parenting stress to adolescent characteristics, parent characteristics, the quality of the adolescent-parent interactions, and stressful life circumstances. It can be used for parents of children between 11 and 19 years. Minimum-maximum value: 7-35. Higher scores mean worse outcome

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  17. Stress Index for Parents of Adolescents-Incompetence/guilt score

    The Stress Index for Parents of Adolescents is a screening and diagnostic instrument that identifies areas of stress in parent-adolescent interactions, allowing examination of the relationship of parenting stress to adolescent characteristics, parent characteristics, the quality of the adolescent-parent interactions, and stressful life circumstances. It can be used for parents of children between 11 and 19 years. Minimum-maximum value: 8-40. Higher scores mean worse outcome

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  18. Caregiver Burden Inventory-Time-dependence burden score

    The Caregiver Burden Inventory comprises 24 closed questions to assess the physical, psychological, emotional, social and financial problems experienced by family caregivers. Minimum-maximum value: 0-20. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  19. Caregiver Burden Inventory-Developmental burden score

    The Caregiver Burden Inventory comprises 24 closed questions to assess the physical, psychological, emotional, social and financial problems experienced by family caregivers. Minimum-maximum value: 0-20. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  20. Caregiver Burden Inventory-Physical burden score

    The Caregiver Burden Inventory comprises 24 closed questions to assess the physical, psychological, emotional, social and financial problems experienced by family caregivers. Minimum-maximum value: 0-16. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  21. Caregiver Burden Inventory-Social burden score

    The Caregiver Burden Inventory comprises 24 closed questions to assess the physical, psychological, emotional, social and financial problems experienced by family caregivers. Minimum-maximum value: 0-20. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  22. Caregiver Burden Inventory-Emotional burden score

    The Caregiver Burden Inventory comprises 24 closed questions to assess the physical, psychological, emotional, social and financial problems experienced by family caregivers. Minimum-maximum value: 0-20. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  23. Family Assessment Device 3-Problem Solving score

    The McMaster Family Assessment Device is a 60-item questionnaire that measures an individual's perceptions of his/her family. Minimum-maximum value: 6-24. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  24. Family Assessment Device 3-Communication score

    The McMaster Family Assessment Device is a 60-item questionnaire that measures an individual's perceptions of his/her family. Minimum-maximum value: 6-40. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  25. Family Assessment Device 3-Roles score

    The McMaster Family Assessment Device is a 60-item questionnaire that measures an individual's perceptions of his/her family. Minimum-maximum value: 6-44. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  26. Family Assessment Device 3-Affective Responsiveness score

    The McMaster Family Assessment Device is a 60-item questionnaire that measures an individual's perceptions of his/her family. Minimum-maximum value: 6-24. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  27. Family Assessment Device 3-Affective Involvement score

    The McMaster Family Assessment Device is a 60-item questionnaire that measures an individual's perceptions of his/her family. Minimum-maximum value: 6-28. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  28. Family Assessment Device 3-Behavior Control score

    The McMaster Family Assessment Device is a 60-item questionnaire that measures an individual's perceptions of his/her family. Minimum-maximum value: 6-36. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

  29. Family Assessment Device 3-General Functioning score

    The McMaster Family Assessment Device is a 60-item questionnaire that measures an individual's perceptions of his/her family. Minimum-maximum value: 6-48. Higher scores mean worse outcome.

    Time frame: at the moment of recruitment (T0), after 1 month (T1), and 2 months after T1 (T2) for both groups

07

Study locations

1 of 1 sites recruiting
  • IRCCSEMedea
    Bosisio Parini, Lecco 23842, Italy
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Oct 2024, 19 months after the start.

Of 285 non-industry interventional studies with no phase under Caregiver Burden, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 31. This study's planned 19 months is above that.

Counting every sponsor, half of 294 studies reached it within 16 months; a quarter within 7 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 20, 2024
First posted
Apr 1, 2024
StartActual
Mar 10, 2023
Primary completionEst.
Oct 2024
CompletionEst.
Nov 30, 2024
Last update
Apr 1, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06339814
Responsible party
Sponsor
First posted
Apr 1, 2024
Start date
Mar 10, 2023
Primary completion
Oct 2024 (estimated)
Completion
Nov 30, 2024 (estimated)
Last update
Apr 1, 2024

Study contacts

Maria Chiara Oprandi
Contact
chiara.oprandi@lanostrafamiglia.it
+39 340 05 18 917
Maria Chiara Oprandi
principal investigator · IRCCS Eugenio Medea

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion